Sage Therapeutics' management has indicated that the cash burn for 2025 is projected to decrease due to a 33% reduction in personnel, which should be finalized before the end of the year.
Sage Therapeutics' management has indicated that the cash burn for 2025 is projected to decrease due to a 33% reduction in personnel, which should be finalized before the end of the year. However, ...